Oxygen bridge bicyclo-[2.2.1]-heptene compound containing different functional side chain structures, as well as preparation and application thereof
A compound and functional technology, applied in the field of oxygen-bridged bicyclo-[2.2.1]-heptene compounds containing different functional side chain structures and their preparation and application, can solve the problem of no protein degradation activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0117] [Example 1] 6-(4-(2,3-dihydroxypropoxy)phenyl)-N-ethyl-5-(4-hydroxyphenyl)-N-phenyl-7-oxo bridge bicyclic Preparation of [2.2.1]-5-heptene-2-sulfonamide (17a)
[0118]
[0119] Weigh 3-(4-(4-(4-hydroxyphenyl)furan-3-yl)phenoxy)propane-1,2-diol (1eq.) and N-ethyl-N-phenylethylene Sulfonamide (1eq.) was placed in a 25mL single-necked round-bottom bottle and then slowly heated to 90°C. After 12 hours of reaction, it was spin-dried, and directly separated and purified by column chromatography. The ratio of eluent was dichloromethane:methanol=60: 1. A yellow solid was obtained with a yield of 61%. 61% yield, mp 96-98℃. 1 H NMR (400MHz, MeOD) δ7.34–7.27 (m, 5H), 7.24–7.16 (m, 2H), 7.12 (dt, J=14.9, 7.5Hz, 2H), 6.88 (dd, J=17.1, 8.7 Hz, 2H), 6.73(dd, J=18.5, 8.6Hz, 2H), 5.44(d, J=10.7Hz, 1H), 5.28(t, J=3.8Hz, 1H), 4.08–4.02(m, 1H ),4.02–3.95(m,2H),3.84–3.75(m,2H),3.67(ddd,J=12.3,10.2,5.0Hz,2H),3.46(td,J=8.4,4.5Hz,1H), 2.20(dd,J=7.6,4.5Hz,1H),1.99(s,1H),1.04(t,J=7.0Hz,3...
Embodiment 2
[0120] [Example 2] 6-(4-(2,3-dihydroxypropoxy)phenyl)-5-(4-hydroxyphenyl)-N-(4-methoxyphenyl)-N-( Preparation of 2,2,2-trifluoroethyl)-7-oxobicyclo[2.2.1]-5-heptene-2-sulfonamide (17b)
[0121]
[0122] The preparation method is as in Example 1, and the product is a yellow solid with a yield of 74%. 1 H NMR (400MHz, MeOD) δ7.32–7.18(m,4H),7.18–7.08(m,2H),7.00–6.90(m,2H),6.87(d,J=8.8Hz,1H),6.83– 6.78(m,2H),6.73–6.68(m,1H),5.47(d,J=5.3Hz,1H),5.31(s,1H),4.42(q,J=8.5Hz,2H),4.08–4.03 (m,1H),4.02–3.95(m,2H),3.78(s,3H),3.73–3.65(m,2H),3.51–3.42(m,1H),2.28–2.19(m,1H),2.09 –2.03(m,1H). 13 C NMR(101MHz,MeOD)δ159.66,159.01,157.38,131.36,130.15,129.24,129.01,128.18,127.98,124.66,115.43,115.14,114.64,114.37,114.18,84.40,82.70,70.36,68.95,62.73,61.30,60.16 , 54.61, 19.49. HRMS (ESI) calcd for C 30 h 30 f 3 NO 8 S[M+Na] + ,644.1536; found 644.1531.
Embodiment 3
[0123] [Example 3] N-(4-chlorophenyl)-6-(4-(2,3-dihydroxypropoxy)phenyl)-5-(4-hydroxyphenyl)-N-(2, Preparation of 2,2-trifluoroethyl)-7-oxobicyclo[2.2.1]-5heptene-2-sulfonamide (17c)
[0124]
[0125] The preparation method is as in Example 1, and the product is a yellow solid with a yield of 56%. 1 H NMR (400MHz, MeOD) δ7.42–7.26(m,4H),7.21(dd,J=12.8,6.1Hz,2H),7.17–7.08(m,2H),6.98–6.86(m,2H), 6.81–6.69(m,2H),5.45(d,J=18.9Hz,1H),5.32(s,1H),4.50(dd,J=16.3,8.1Hz,2H),4.06(dd,J=12.5, 7.5Hz, 1H), 4.03–3.94(m, 2H), 3.69(dd, J=11.2, 4.9Hz, 2H), 3.50(d, J=7.8Hz, 1H), 2.22–2.13(m, 1H), 2.03(s,1H). 13 C NMR(101MHz,MeOD)δ159.02,157.42,140.79,137.96,136.37,134.01,130.20,129.23,129.11,128.88,128.23,128.04,124.61,123.56,115.41,115.14,114.63,114.37,84.38,82.73,70.36,68.94 ,62.74,61.83,60.16,30.18,19.48.HRMS(ESI)calcd for C 29 h 27 CIF 3 NO 7 S[M+Na] + ,648.1041; found 648.1038.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com